“Curious about genetic testing and what the results will tell you?” asks Chris Woodward of LifeZette. “Be sure you’re comfortable with privacy issues (or lack thereof).” Woodward writes:
Let the buyer beware! That is the message for people thinking about using home kits promising personal genetic information and details in exchange for something as simple as a saliva sample. The firm 23andMe is the latest company looking to become a household name — and the U.S. Food and Drug Administration (FDA) recently granted it authorization to market genetic reports on personal risk for certain diseases.
The authorization includes reports on genetic risk for 10 conditions, including late-onset Alzheimer’s disease, Parkinson’s disease, and harmful blood clots, among others.
View article →